{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34624906", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "30"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1055/a-1628-8132"], "Journal": {"ISSN": "1439-0221", "JournalIssue": {"Volume": "88", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Oct"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Medicinal Plants for the Treatment of Mental Diseases in Pregnancy: An In Vitro Safety Assessment.", "Pagination": {"StartPage": "1036", "EndPage": "1046", "MedlinePgn": "1036-1046"}, "Abstract": {"AbstractText": ["Pregnancy is a critical period for medical care, during which the well-being of woman and fetus must be considered. This is particularly relevant in managing non-psychotic mental disorders since treatment with central nervous system-active drugs and untreated NMDs may have negative effects. Some well-known herbal preparations (phytopharmaceuticals), including St.\u00a0John's wort, California poppy, valerian, lavender, and hops, possess antidepressant, sedative, anxiolytic, or antidepressant properties and could be used to treat mental diseases such as depression, restlessness, and anxiety in pregnancy. Our goal was to assess their safety <i>in vitro</i>, focusing on cytotoxicity, induction of apoptosis, genotoxicity, and effects on metabolic properties and differentiation in cells widely used as a placental cell model (BeWo b30 placenta choriocarcinoma cells). The lavender essential oil was inconspicuous in all experiments and showed no detrimental effects. At low-to-high concentrations, no extract markedly affected the chosen safety parameters. At an artificially high concentration of 100\u2009\u00b5g/mL, extracts from St.\u00a0John's wort, California poppy, valerian, and hops had minimal cytotoxic effects. None of the extracts resulted in genotoxic effects or altered glucose consumption or lactate production, nor did they induce or inhibit BeWo b30 cell differentiation. This study suggests that all tested preparations from St.\u00a0John's wort, California poppy, valerian, lavender, and hops, in concentrations up to 30\u2009\u00b5g/mL, do not possess any cytotoxic or genotoxic potential and do not compromise placental cell viability, metabolic activity, and differentiation. Empirical and clinical studies during pregnancy are needed to support these <i>in vitro</i> data."], "CopyrightInformation": "The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)."}, "AuthorList": [{"Identifier": ["0000-0001-8887-6194"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland."}, {"Identifier": [], "Affiliation": "Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland."}], "LastName": "Spiess", "ForeName": "Deborah", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, University of Freiburg, Faculty of Medicine, Freiburg, Germany."}, {"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland."}], "LastName": "Winker", "ForeName": "Moritz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland."}], "LastName": "Chauveau", "ForeName": "Antoine", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland."}], "LastName": "Abegg", "ForeName": "Vanessa Fabienne", "Initials": "VF"}, {"Identifier": ["0000-0001-5962-6516"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland."}], "LastName": "Potterat", "ForeName": "Olivier", "Initials": "O"}, {"Identifier": ["0000-0001-9331-273X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland."}], "LastName": "Hamburger", "ForeName": "Matthias", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, University of Freiburg, Faculty of Medicine, Freiburg, Germany."}, {"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland."}], "LastName": "Gr\u00fcndemann", "ForeName": "Carsten", "Initials": "C"}, {"Identifier": ["0000-0002-4489-0952"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland."}], "LastName": "Sim\u00f5es-W\u00fcst", "ForeName": "Ana Paula", "Initials": "AP"}], "GrantList": [{"GrantID": "Swiss National Science Foundation", "Agency": "Sinergia CRSII5_177260", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Anxiety Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypnotics and Sedatives"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactates"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Anti-Anxiety Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Glucose"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hypnotics and Sedatives"}, {"QualifierName": [], "DescriptorName": "Lactates"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Mental Disorders"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Placenta"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Valerian"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Berger A, Bachmann N, Signorell A, Erdin R, Oelhafen S, Reich O, Cignacco E. Perinatal mental disorders in Switzerland: prevalence estimates and use of mental-health services. Swiss Med Wkly. 2017;147:w14417.", "ArticleIdList": ["28322424"]}, {"Citation": "Chisolm M S, Payne J L. Management of psychotropic drugs during pregnancy. BMJ. 2015;351:h5918.", "ArticleIdList": ["26791406"]}, {"Citation": "Stewart D, Vigod S.Antenatal use of antidepressants and risk of teratogenicity and adverse pregnancy outcomes: selective serotonin reuptake inhibitors (SSRIs). (October 9, 2020)Accessed February 11, 2021 at:https://www.uptodate.com/contents/antenatal-use-of-antidepressants-and-risk-of-teratogenicity-and-adverse-pregnancy-outcomes-selective-serotonin-reuptake-inhibitors-ssris"}, {"Citation": "Molenaar N M, Kamperman A M, Boyce P, Bergink V. Guidelines on treatment of perinatal depression with antidepressants: an international review. Aust N Z J Psychiatry. 2018;52:320\u2013327.", "ArticleIdList": ["PMC5871019", "29506399"]}, {"Citation": "Hanley G E, Oberlander T F. The effect of perinatal exposures on the infant: antidepressants and depression. Best Pract Res Clin Obstet Gynaecol. 2014;28:37\u201348.", "ArticleIdList": ["24100223"]}, {"Citation": "Grote N K, Bridge J A, Gavin A R, Melville J L, Iyengar S, Katon W J. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67:1012\u20131024.", "ArticleIdList": ["PMC3025772", "20921117"]}, {"Citation": "Iqbal M M, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiat Serv. 2002;53:39\u201349.", "ArticleIdList": ["11773648"]}, {"Citation": "Salter S, Brownie S. Treating primary insomnia: the efficacy of valerian and hops. Aust Fam Physician. 2010;39:433\u2013437.", "ArticleIdList": ["20628685"]}, {"Citation": "Dimpfel W, Suter A. Sleep improving effects of a single dose administration of a valerian/hops fluid extract. A double-blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. Eur J Med Res. 2008;13:1\u20135.", "ArticleIdList": ["18559301"]}, {"Citation": "Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L . J Ethnopharmacol. 2008;116:383\u2013396.", "ArticleIdList": ["18308492"]}, {"Citation": "Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties . Phytomedicine. 2008;15:2\u201315.", "ArticleIdList": ["18160026"]}, {"Citation": "Holst L, Nordeng H, Haavik S. Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome. Pharmacoepidemiol Drug Saf. 2008;17:151\u2013159.", "ArticleIdList": ["17992658"]}, {"Citation": "Kennedy D A, Lupattelli A, Koren G, Nordeng H. Herbal medicine use in pregnancy: results of a multinational study. BMC Complem Altern M. 2013;13:355.", "ArticleIdList": ["PMC4029224", "24330413"]}, {"Citation": "Trabace L, Tucci P, Ciuffreda L, Matteo M, Fortunato F, Campolongo P, Trezza V, Cuomo V. \u201cNatural\u201d relief of pregnancy-related symptoms and neonatal outcomes: above all do no harm. J Ethnopharmacol. 2015;174:396\u2013402.", "ArticleIdList": ["26325431"]}, {"Citation": "Schilcher H, Kammerer S, Wegener T. M\u00fcnchen: Urban & Fischer; 2016. Leitfaden Phytotherapie."}, {"Citation": "Donelli D, Antonelli M, Bellinazzi C, Gensini G F, Firenzuoli F. Effects of lavender on anxiety: a systematic review and meta-analysis. Phytomedicine. 2019;65:153099.", "ArticleIdList": ["31655395"]}, {"Citation": "Woelk H, Schl\u00e4fke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine. 2010;17:94\u201399.", "ArticleIdList": ["19962288"]}, {"Citation": "Kasper S, Gastpar M, M\u00fcller W E, Volz H P, M\u00f6ller H J, Schl\u00e4fke S, Dienel A. Lavender oil preparation Silexan is effective in generalized anxiety disorder\u2013a randomized, double-blind comparison to placebo and paroxetine. Int J Neuropsychopharmacol. 2014;17:859\u2013869.", "ArticleIdList": ["24456909"]}, {"Citation": "European Medicines Agency  EMA/HMPC/680372/2013 \u2013 European Union herbal monograph on Eschscholzia californica Cham., herba. (January 28, 2015)Accessed June 2, 2021 at:https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-eschscholzia-californica-cham-herba_en.pdf"}, {"Citation": "European Medicines Agency  EMA/HMPC/680375/2013\u2013Assessment report on Eschscholzia californica Cham., herba. (January 28, 2015)Accessed June 2, 2021 at:https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-eschscholzia-californica-cham-herba_en.pdf"}, {"Citation": "Rolland A, Fleurentin J, Lanhers M C, Younos C, Misslin R, Mortier F, Pelt J M. Behavioural effects of the American traditional plant Eschscholzia californica : sedative and anxiolytic properties . Planta Med. 1991;57:212\u2013216.", "ArticleIdList": ["1680240"]}, {"Citation": "Rolland A, Fleurentin J, Lanhers M, Misslin R, Mortier F. Neurophysiological effects of an extract of Eschscholzia californica Cham. (Papaveraceae) . Phytother Res. 2001;15:377\u2013381.", "ArticleIdList": ["11507727"]}, {"Citation": "Fedurco M, Gregorov\u00e1 J, \u0160ebrlov\u00e1 K, Kantorov\u00e1 J, Pe\u0161 O, Baur R, Sigel E, T\u00e1borsk\u00e1 E. Modulatory effects of Eschscholzia californica alkaloids on recombinant GABA A receptors . Biochem Res Int. 2015;2015:617620.", "ArticleIdList": ["PMC4609799", "26509084"]}, {"Citation": "Dingermann T, Loew D. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 2003. Phytopharmakologie: experimentelle und klinische Pharmakologie pflanzlicher Arzneimittel."}, {"Citation": "Cui Y H, Zheng Y. A meta-analysis on the efficacy and safety of St John\u02bcs wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults. Neuropsychiatr Dis Treat. 2016;12:1715\u20131723.", "ArticleIdList": ["PMC4946846", "27468236"]}, {"Citation": "Nicolussi S, Drewe J, Butterweck V, Meyer zu Schwabedissen H E. Clinical relevance of St. John\u02bcs wort drug interactions revisited. Br J Pharmacol. 2020;177:1212\u20131226.", "ArticleIdList": ["PMC7056460", "31742659"]}, {"Citation": "Kolding L, Pedersen L H, Henriksen T B, Olsen J, Grzeskowiak L E. Hypericum perforatum use during pregnancy and pregnancy outcome . Reprod Toxicol. 2015;58:234\u2013237.", "ArticleIdList": ["26536653"]}, {"Citation": "Moretti M E, Maxson A, Hanna F, Koren G. Evaluating the safety of St. John\u02bcs Wort in human pregnancy. Reprod Toxicol. 2009;28:96\u201399.", "ArticleIdList": ["19491000"]}, {"Citation": "Stewart D, Pallivalappila A, Shetty A, Pande B, McLay J. Healthcare professional views and experiences of complementary and alternative therapies in obstetric practice in North East Scotland: a prospective questionnaire survey. BJOG. 2014;121:1015\u20131019.", "ArticleIdList": ["24512627"]}, {"Citation": "Pallivalappila A R, Stewart D, Shetty A, Pande B, McLay J S. Complementary and alternative medicines use during pregnancy: A systematic review of pregnant women and healthcare professional views and experiences. Evid Based Complement Alternat Med. 2013;2013:1\u201310.", "ArticleIdList": ["PMC3806151", "24194778"]}, {"Citation": "Petersen I, McCrea R L, Lupattelli A, Nordeng H. Women\u02bcs perception of risks of adverse fetal pregnancy outcomes: A large-scale multinational survey. BMJ Open. 2015;5:e007390.", "ArticleIdList": ["PMC4458601", "26033946"]}, {"Citation": "European Medicines Agency  EMA/HMPC/682384/2013\u2013Community herbal monograph on Humulus lupulus L., flos. (May 6, 2014)Accessed June 2, 2021 at:https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-humulus-lupulus-l-flos_en.pdf"}, {"Citation": "European Medicines Agency  EMA/HMPC/150848/2015\u2013European Union herbal monograph on Valeriana officinalis L., radix. (February 2, 2016)Accessed June 2, 2021 at:https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-valeriana-officinalis-l-radix_en.pdf"}, {"Citation": "European Medicines Agency  EMA/HMPC/143181/2010\u2013Community herbal monograph on Lavandula angustifolia Miller, aetheroleum. (March\u00a027, 2012)Accessed June 2, 2021 at:https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-lavandula-angustifolia-miller-aetheroleum_en.pdf"}, {"Citation": "European Medicines Agency  EMA/HMPC/101304/2008\u2013Community herbal monograph on Hypericum perforatum L., herba (well-established medicinal use). (November 12, 2009)Accessed June 2, 2021 at:https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-hypericum-perforatum-l-herba-well-established-medicinal-use_en.pdf"}, {"Citation": "Spiess D, Abegg V F, Chauveau A, Treyer A, Reinehr M, Oufir M, Duong E, Potterat O, Hamburger M, Sim\u00f5es-W\u00fcst A P. Placental passage of humulone and protopine in an ex vivo human perfusion system . Planta Med. 2021 doi: 10.1055/a-1578-3803.", "ArticleIdList": ["10.1055/a-1578-3803", "PMC8585570", "34530480"]}, {"Citation": "Orendi K, Gauster M, Moser G, Meiri H, Huppertz B. The choriocarcinoma cell line BeWo: Syncytial fusion and expression of syncytium-specific proteins. Reproduction. 2010;140:759\u2013766.", "ArticleIdList": ["20696850"]}, {"Citation": "Medicinal product information search platform (AIPS) Accessed April 9, 2021 at:https://www.swissmedicinfo.ch"}, {"Citation": "Swiss Federal Statistical Office  Durchschnittliches K\u00f6rpergewicht (in kg). (February 28, 2019)Accessed February 11, 2021 at:https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit.assetdetail.7586025.html"}, {"Citation": "Da Conceicao A O, Takser L, Lafond J. Effect of St. John\u02bcs wort standardized extract and hypericin on in vitro placental calcium transport . J Med Food. 2010;13:934\u2013942.", "ArticleIdList": ["20553141"]}, {"Citation": "Nakamura K, Aizawa K, Yamauchi J, Tanoue A. Hyperforin inhibits cell proliferation and differentiation in mouse embryonic stem cells. Cell Prolif. 2013;46:529\u2013537.", "ArticleIdList": ["PMC6495937", "24033566"]}, {"Citation": "Sch\u00e4fer A M, Potterat O, Seibert I, Fertig O, Meyer zu Schwabedissen H E. Hyperforin-induced activation of the pregnane X receptor is influenced by the organic anion-transporting polypeptide 2B1. Mol Pharmacol. 2019;95:313\u2013323.", "ArticleIdList": ["30573512"]}, {"Citation": "Hui-Lian W, Dong-Fang Z, Zhao-Feng L, Yang L, Qian-Rong L, Yu-Zhen W. In vitro study on the genotoxicity of dichloromethane extracts of valerian (DEV) in human endothelial ECV304 cells and the effect of vitamins E and C in attenuating the DEV-induced DNA damages . Toxicol Appl Pharmacol. 2003;188:36\u201341.", "ArticleIdList": ["12668120"]}, {"Citation": "Al-Majed A A, Al-Yahya A A, Al-Bekairi A, Al-Shabanah O, Qureshi S. Studies on the cytological and biochemical effects of valerian in somatic and germ cells of Swiss albino mice. Food Chem Toxicol. 2006;44:1830\u20131837.", "ArticleIdList": ["16879905"]}, {"Citation": "Miranda C, Stevens J, Helmrich A, Henderson M, Rodriguez R, Yang Y H, Deinzer M, Barnes D, Buhler D. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops ( Humulus lupulus ) in human cancer cell lines . Food Chem Toxicol. 1999;37:271\u2013285.", "ArticleIdList": ["10418944"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "8", "Hour": "20", "Minute": "36"}, {"Year": "2021", "Month": "10", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34624906", "PMC9519192", "10.1055/a-1628-8132"]}}], "PubmedBookArticle": []}